NASDAQ:LSAQ LifeSci Acquisition II (LSAQ) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free LSAQ Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$9.01▼$14.1052-Week Range N/AVolumeN/AAverage Volume53,514 shsMarket Capitalization$57.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisSocial MediaStock AnalysisSocial Media Get LifeSci Acquisition II alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About LifeSci Acquisition IILifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.Read More Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. LSAQ Stock News HeadlinesDecember 7, 2023 | money.usnews.comNew Providence Acquisition Corp II - Ordinary Shares - Class AMay 23, 2023 | morningstar.comSeaport Global Acquisition II Corp Units (1 Ord Class A & 1/2 War) SGIIU Stock QuoteMay 12, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.April 20, 2023 | morningstar.comM3 Brigade Acquisition II Corp Ordinary Shares - Class AMarch 11, 2023 | foxnews.comYankees' big deadline acquisition admits he wasn't healthy when traded to New YorkOctober 7, 2021 | finance.yahoo.comWith SPAC deal done, Triangle science company hits public marketsOctober 7, 2021 | finance.yahoo.comScience 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCEOctober 4, 2021 | markets.businessinsider.comOctober SPAC Merger Calendar: A Look At Upcoming Votes, Stocks To WatchMay 12, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.July 24, 2021 | investing.comLifesci Acquisition II Corp (LSAQ)See More Headlines Receive LSAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeSci Acquisition II and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/12/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:LSAQ CUSIPN/A CIK1819113 Weblifesciacquisition.com Phone646-899-1200FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio4.07 Quick Ratio4.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.50 per share Price / BookN/AMiscellaneous Outstanding Shares10,011,000Free FloatN/AMarket Cap$57.56 million OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Andrew Ian McDonald Ph.D. (Age 47)Chairman & CEO Mr. David Dobkin (Age 42)CFO, Head of Strategy & Director Mr. Michael Yehuda Rice (Age 56)COO & Director Key CompetitorsbioAffinity TechnologiesNASDAQ:BIAFInotivNASDAQ:NOTVHyperfineNASDAQ:HYPRCelularityNASDAQ:CELUReneo PharmaceuticalsNASDAQ:RPHMView All Competitors LSAQ Stock Analysis - Frequently Asked Questions When did LifeSci Acquisition II IPO? LifeSci Acquisition II (LSAQ) raised $75 million in an IPO on Friday, November 20th 2020. The company issued 7,500,000 shares at a price of $10.00 per share. LifeSci Capital and Ladenburg Thalmann acted as the underwriters for the IPO. This page (NASDAQ:LSAQ) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeSci Acquisition II Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.